Leslie W. Kreis bought $99k of CGTX
director at COGNITION THERAPEUTICS INC. 71,000 shares at an average of $1.40, traded Nov 16, 2022, filed Nov 17, 2022.
Score components
- +15RoleDirector
- +10Trade size$99k at market
- +6Relative to holdingsHoldings up 22%
- +8Price context87% below the 52-week high
- +15Cluster5 insiders buying within 14 days
- +5Repeat buying2 buys in 90 days
- 0Track recordToo few past buys to judge (1 with prices)
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001104659-22-119719, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Nov 16, 2022 | POpen-market purchase Common Stockindirect: By Bios Fund III NT, LP | +8,722 | $1.40 | $12k | 324,760 | Nov 17, 2022 |
| Nov 16, 2022 | POpen-market purchase Common Stockindirect: By Bios Fund III QP, LP | +54,009 | $1.40 | $76k | 2,009,686 | Nov 17, 2022 |
| Nov 16, 2022 | POpen-market purchase Common Stockindirect: Bios Fund III, LP | +8,269 | $1.40 | $12k | 307,877 | Nov 17, 2022 |
Related signals
Other insiders at COGNITION THERAPEUTICS INC and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 38Weak | COGNITION THERAPEUTICS INC | Anthony Caggiano Chief Medical Officer | $11k 10,000 shares | +1% | |
| 43Moderate | COGNITION THERAPEUTICS INC | Lisa Ricciardi CEO & President | $10k 9,175 shares | +1% | |
| 45Moderate | COGNITION THERAPEUTICS INC | John Brendan Doyle Chief Financial Officer | $11k 10,000 shares | +2% | |
| 38Weak | CGTXbuy COGNITION THERAPEUTICS INC | Lisa Ricciardi CEO & President | $30k 38,851 shares | - | |
| 33Weak | CGTXbuy COGNITION THERAPEUTICS INC | Lisa Ricciardi CEO & President | $9,975 5,700 shares | +2% | |
| 49Moderate | COGNITION THERAPEUTICS INC | Aaron G.L. Fletcher director, owner | $43k 16,064 shares | +5% | |
| 49Moderate | COGNITION THERAPEUTICS INC | Leslie W. Kreis director, owner | $43k 16,064 shares | +5% | |
| 51Moderate | COGNITION THERAPEUTICS INC | Ellen B Richstone director | $27k 10,000 shares | - | |
| 59Moderate | COGNITION THERAPEUTICS INC | Aaron G.L. Fletcher director | $99k 71,000 shares | +22% | |
| 73Notable | COGNITION THERAPEUTICS INC | Aaron G.L. Fletcher director | $1.8M 1,500,000 shares | +1138% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.